Showing results (1591-1600 of 1,633) with videos related to

Sort By:
Pageof 164
Frontiers in Immunology|September 4, 2023
Corrigendum: Cross-reactive humoral and CD4+ T cell responses to Mu and Gamma SARS-CoV-2 variants in a Colombian populationFabiola Martel, Juliana Cuervo-Rojas, Juana Ángel, et al.
Systematic Reviews|February 13, 2019
Inappropriateness of health care in Canada: a systematic review protocolJanet E Squires, Ian D Graham, Doris Grinspun, et al.
JAMA Psychiatry|July 30, 2013
A comprehensive family-based replication study of schizophrenia genesKarolina A Aberg, Youfang Liu, Jozsef Bukszár, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 25, 2019
Consolidative thoracic radiotherapy in stage IV small cell lung cancer: Selection of patients amongst European IASLC and ESTRO expertsPaul Martin Putora, Markus Glatzer, Dirk De Ruysscher, et al.
Biological Psychiatry|April 26, 2011
The AVPR1A gene and substance use disorders: association, replication, and functional evidenceBrion S Maher, Vladimir I Vladimirov, Shawn J Latendresse, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|March 1, 2022
Inappropriate use of clinical practices in Canada: a systematic reviewJanet E Squires, Danielle Cho-Young, Laura D Aloisio, et al.
Blood|June 20, 2025
Somatic IRF4 Mutations and Thymic Tropism in Primary Mediastinal Large B-cell LymphomaShinya Rai, Gerben Duns, Fabian Frontzek, et al.
Human Molecular Genetics|October 29, 2013
CNV analysis in a large schizophrenia sample implicates deletions at 16p12.1 and SLC1A1 and duplications at 1p36.33 and CGNL1Elliott Rees, James T R Walters, Kimberly D Chambert, et al.
Molecular Cell|May 22, 2025
A specific form of cPRC1 containing CBX4 is co-opted to mediate oncogenic gene repression in diffuse midline gliomaEimear Lagan, Dáire Gannon, Ademar Jesus Silva, et al.
Lancet (London, England)|December 9, 2017
Preliminary aggregate safety and immunogenicity results from three trials of a purified inactivated Zika virus vaccine candidate: phase 1, randomised, double-blind, placebo-controlled clinical trialsKayvon Modjarrad, Leyi Lin, Sarah L George, et al.
Pageof 164